Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioDiscovery Initiates Software Donation Program to Benefit Pediatric Research

Published: Monday, January 07, 2013
Last Updated: Monday, January 07, 2013
Bookmark and Share
Company to donate up to $100,000 worth of software licenses per year to eligible scientists working in pediatric research.

BioDiscovery, Inc. has recently launched a new software donation program to assist scientists and benefit pediatric research.

The program is aimed towards those researchers with limited resources but promising projects that will advance diagnosis and treatment of pediatric diseases.

BioDiscovery provides software solutions and services for DNA copy number, gene and miRNA expression, and methylation analysis from microarray and next-generation sequencing (NGS) technologies.

“We are really excited to be able to fund this new program to assist promising young scientists make advances in pediatric research,” said Dr. Soheil Shams, President of BioDiscovery, Inc.

Dr. Shams continued, “We know there are brilliant researchers especially those just starting their careers who have great ideas and projects but may not yet have the funds to move forward with their research. We recognize the heartache children and their families face when afflicted with a disease. Many disorders don’t have any treatment options and some cannot even be diagnosed. We believe that limitations on funding should not be an impediment in finding better treatments, especially for pediatric maladies.”

BioDiscovery has allocated $100,000 worth of software licenses per year that it will be donating to eligible researchers working on pediatric diseases.

Those interested can view the requirements and fill out the application form on the BioDiscovery website. BioDiscovery’s software solutions are designed for the end-user scientist for visualization and analysis of genomic data from aCGH, SNP, methylation and gene/miRNA expression microarrays as well as from NGS technologies.

BioDiscovery’s software is platform independent and available for Mac OS X, Linux and Windows operating systems. BioDiscovery Nexus Copy Number is the leading platform independent and user friendly application for DNA copy number analysis.

Nexus Copy Number can integrate and process together, in a single project, data from commercial array platforms such as Agilent, Affymetrix, Illumina, Roche NimbleGen, Next-Gen read depth, as well as custom arrays.

With its free access to a web-based repository for querying, and storing genomic data from any location across the globe, Nexus Copy Number is a powerful solution for large groups such as special consortia and collaborative research networks.

Nexus Expression is a complete package for analysis and visualization of gene and microRNA expression array data to identify differentially regulated probes, cluster samples and probes and identify common biological themes through gene set enrichment.

ImaGene is recognized by industry experts as the most complete solution for array image analysis with the highest quality results and the easiest to use microarray analysis user interface.

With single click automation, integrated advanced quality control parameters, numerous patented segmentation and contamination removal algorithms, and hundreds of active customers worldwide, ImaGene remains the leader in microarray image analysis.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioDiscovery Awarded National Institutes of Health SBIR Grant
SBIR Phase I grant to improve the copy number variation data from TCGA.
Thursday, July 10, 2014
N-of-One and BioDiscovery Partner
Partnership equips laboratories and oncologists with a foundation for genomic data analysis through to therapeutic options.
Tuesday, March 25, 2014
BioDiscovery and AGRE Enter into a Co-Promotion Agreement
Agreement allows AGRE to provide copy number and allelic event data to its research users.
Wednesday, September 19, 2012
Fox Chase Cancer Center Adopts Nexus Copy Number and Nexus Expression
The center's Keystone Program in Blood Cell Development and Cancer gains a site license for two bioinformatics software programs from BioDiscovery.
Wednesday, February 11, 2009
Scientific News
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!